News & Press Featured Press Release Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025 BusinessWire • May 13, 2025 Read More All In The News Press Release In The News RNA That Lasts Longer and Lands Exactly Where It Should Drug Target Review • December 12, 2025 In The News Circular RNA: The Next Frontier for RNA Therapeutics? Technology Networks • November 4, 2025 Press Release Sail Biomedicines Appoints Martin Mackay, Ph.D., to Its Board of Directors October 23, 2025 Press Release Sail Biomedicines to Present New Preclinical Data on Malaria eRNA™ Vaccine Candidates at the 2025 Grand Challenges Annual Meeting June 2, 2025 In The News Q&A: Is the key to personalised medicine programmability? Pharmaceutical Manufacturer • May 30, 2025 In The News Designing Our Way Toward Circular RNA Medicines With AI Advancing RNA • May 30, 2025 Press Release Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025 BusinessWire • May 13, 2025 Press Release Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board Business Wire • April 2, 2024 Press Release Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines Business Wire • January 5, 2024 Load More In The News RNA That Lasts Longer and Lands Exactly Where It Should Drug Target Review • December 12, 2025 In The News Circular RNA: The Next Frontier for RNA Therapeutics? Technology Networks • November 4, 2025 In The News Q&A: Is the key to personalised medicine programmability? Pharmaceutical Manufacturer • May 30, 2025 In The News Designing Our Way Toward Circular RNA Medicines With AI Advancing RNA • May 30, 2025 Press Release Sail Biomedicines Appoints Martin Mackay, Ph.D., to Its Board of Directors October 23, 2025 Press Release Sail Biomedicines to Present New Preclinical Data on Malaria eRNA™ Vaccine Candidates at the 2025 Grand Challenges Annual Meeting June 2, 2025 Press Release Sail Biomedicines Presents Preclinical Data on In Vivo eRNA™ CAR-T Candidate for Autoimmune Diseases at ASGCT 2025 BusinessWire • May 13, 2025 Press Release Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board Business Wire • April 2, 2024 Press Release Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines Business Wire • January 5, 2024 Press Release Sail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D’Amelio to Its Board Business Wire • January 4, 2024 Press Release Sail Biomedicines Receives Grants to Fight Malaria by Developing a New Class of RNA Medicines Business Wire • January 3, 2024 Press Release Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to form Sail Biomedicines Flagship Pioneering • October 19, 2023
